Arrowhead Pharmaceuticals Inc. announced that the board of directors appointed veteran pharmaceutical industry executive Victoria Vakiener, as an independent director of the company, with a term beginning effective May 2, 2022. Ms. Vakiener currently serves on the board of directors of Chimerix, a clinical-stage biopharmaceutical company.